Biology and Environmental Chemistry Division, Sustainable System Research Laboratory, Central Research Institute of Electric Power Industry (CRIEPI), Chiba, Japan.
Radiat Res. 2023 Aug 1;200(2):188-216. doi: 10.1667/RADE-23-00030.1.
For radiation protection purposes, noncancer effects with a threshold-type dose-response relationship have been classified as tissue reactions (formerly called nonstochastic or deterministic effects), and equivalent dose limits aim to prevent occurrence of such tissue reactions. Accumulating evidence demonstrates increased risks for several late occurring noncancer effects at doses and dose rates much lower than previously considered. In 2011, the International Commission on Radiological Protection (ICRP) issued a statement on tissue reactions to recommend a threshold of 0.5 Gy to the lens of the eye for cataracts and to the heart and brain for diseases of the circulatory system (DCS), independent of dose rate. Literature published thereafter continues to provide updated knowledge. Increased risks for cataracts below 0.5 Gy have been reported in several cohorts (e.g., including in those receiving protracted or chronic exposures). A dose threshold for cataracts is less evident with longer follow-up, with limited evidence available for risk of cataract removal surgery. There is emerging evidence for risk of normal-tension glaucoma and diabetic retinopathy, but the long-held tenet that the lens represents among the most radiosensitive tissues in the eye and in the body seems to remain unchanged. For DCS, increased risks have been reported in various cohorts, but the existence or otherwise of a dose threshold is unclear. The level of risk is less uncertain at lower dose and lower dose rate, with the possibility that risk per unit dose is greater at lower doses and dose rates. Target organs and tissues for DCS are also unknown, but may include heart, large blood vessels and kidneys. Identification of potential factors (e.g., sex, age, lifestyle factors, coexposures, comorbidities, genetics and epigenetics) that may modify radiation risk of cataracts and DCS would be important. Other noncancer effects on the radar include neurological effects (e.g., Parkinson's disease, Alzheimer's disease and dementia) of which elevated risk has increasingly been reported. These late occurring noncancer effects tend to deviate from the definition of tissue reactions, necessitating more scientific developments to reconsider the radiation effect classification system and risk management. This paper gives an overview of historical developments made in ICRP prior to the 2011 statement and an update on relevant developments made since the 2011 ICRP statement.
出于辐射防护的目的,具有阈值型剂量-反应关系的非癌症效应已被归类为组织反应(以前称为非随机或确定性效应),等效剂量限值旨在预防此类组织反应的发生。越来越多的证据表明,在以前认为的低得多的剂量和剂量率下,几种迟发性非癌症效应的风险增加。2011 年,国际辐射防护委员会(ICRP)发表了一份关于组织反应的声明,建议将晶状体白内障和心血管系统疾病(DCS)的剂量阈值设定为 0.5Gy,而与剂量率无关。此后发表的文献继续提供最新的知识。在几个队列中报告了 0.5Gy 以下白内障风险增加的情况(例如,包括接受长期或慢性暴露的队列)。随着随访时间的延长,白内障的剂量阈值变得不那么明显,对于白内障摘除手术风险的证据有限。有越来越多的证据表明正常眼压性青光眼和糖尿病性视网膜病变的风险,但晶状体仍然是眼睛和身体中最敏感的组织之一的长期观点似乎没有改变。对于 DCS,各种队列中都报告了风险增加,但剂量阈值是否存在尚不清楚。在较低剂量和较低剂量率下,风险水平的不确定性较小,并且在较低剂量和剂量率下,单位剂量的风险可能更大。DCS 的靶器官和组织也未知,但可能包括心脏、大血管和肾脏。确定可能改变白内障和 DCS 辐射风险的潜在因素(例如,性别、年龄、生活方式因素、共同暴露、合并症、遗传学和表观遗传学)将是重要的。其他已引起关注的非癌症效应包括神经系统效应(例如,帕金森病、阿尔茨海默病和痴呆症),其风险增加的情况越来越多。这些迟发性非癌症效应往往偏离组织反应的定义,需要更多的科学发展来重新考虑辐射效应分类系统和风险管理。本文概述了 ICRP 在 2011 年声明之前的历史发展,并更新了自 2011 年 ICRP 声明以来的相关发展。